On-demand Therapy for Hereditary Angioedema

被引：3
|
作者：
Bernstein, Jonathan A. [1 ]
机构：
[1] Univ Cincinnati, Allergy Sect, Div Immunol, Dept Internal Med,Coll Med, Cincinnati, OH 45267 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2013年 / 33卷 / 04期
关键词：
Hereditary angioedema; On-demand therapies; Berinert; Ecallantide; Icatibant; Ruconest; Guidelines; RECOMBINANT HUMAN C1-INHIBITOR; C1 INHIBITOR CONCENTRATE; ACUTE ATTACKS; RECEPTOR ANTAGONIST; CONESTAT ALPHA; MANAGEMENT; ECALLANTIDE; DEFICIENCY; ICATIBANT; EFFICACY;
D O I：
10.1016/j.iac.2013.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Consensus guidelines on hereditary angioedema (HAE) recommend that all patients have access to on-demand treatment of acute attacks. A recent patientcentric guideline recommended that at least 2 on-demand therapies be available because patients often have heterogeneous responses to different medications. Self-administration of therapeutic agents, or administration under supervision by a health care provider in the home setting, is the preferred treatment approach. Future studies are needed to show the benefits of acute on-demand therapies at improving quality of life and reducing morbidity and mortality in patients with HAE.
引用
收藏
页码：487 / +
页数：10
相关论文
共 50 条
  • [21] The use of tranexamic acid for on-demand and prophylactic treatment of hereditary angioedema-A systematic review
    Horiuchi, Takahiko
    Hide, Michihiro
    Yamashita, Kouhei
    Ohsawa, Isao
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2018, 1 (04) : 126 - 138
  • [22] On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
    Emel Aygören-Pürsün
    Inmaculada Martinez-Saguer
    Eva Rusicke
    Thomas Klingebiel
    Wolfhart Kreuz
    Allergy, Asthma & Clinical Immunology, 6 (1)
  • [23] Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients
    Federici, Carlo
    Perego, Francesca
    Borsoi, Ludovica
    Crosta, Valentina
    Zanichelli, Andrea
    Gidaro, Antonio
    Tarricone, Rosanna
    Cicardi, Marco
    BMJ OPEN, 2018, 8 (07):
  • [24] Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks
    Grumach, A.
    Van Kooten, S.
    Heckmann, M.
    Danese, S.
    Goga, L.
    Garcez, T.
    ALLERGY, 2023, 78
  • [25] KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results
    Maetzel, Andreas
    Smith, Michael D.
    Duckworth, Edward J.
    Hampton, Sally L.
    De Donatis, Gian Marco
    Murugesan, Nivetha
    Rushbrooke, Louise J.
    Li, Lily
    Francombe, Danielle
    Feener, Edward P.
    Yea, Christopher M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 2034 - 2042
  • [26] Correction: The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks
    Stephen D. Betschel
    Teresa Caballero
    Douglas H. Jones
    Hilary J. Longhurst
    Michael Manning
    Sally van Kooten
    Markus Heckmann
    Sherry Danese
    Ledia Goga
    Autumn Ford Burnette
    Allergy, Asthma & Clinical Immunology, 21 (1)
  • [27] Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies
    Valerieva, A.
    Van Kooten, S.
    Heckmann, M.
    Danese, S.
    Goga, L.
    Longhurst, H.
    ALLERGY, 2023, 78
  • [28] Berotralstat Reduces Use of On-demand Medication in Hereditary Angioedema (HAE) Patients Previously Treated with Prophylactic Therapies
    Gower, Richard
    Busse, Paula
    Best, Jessica
    Murray, Sharon
    Iocca, Heather
    Kinaciyan, Tamar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB146 - AB146
  • [29] HEREDITARY ANGIOEDEMA AND HEPARIN THERAPY
    COLMAN, RW
    ANNALS OF INTERNAL MEDICINE, 1976, 85 (03) : 399 - 399
  • [30] Hereditary angioedema: Optimal therapy
    Sheffer, Albert L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (04) : 756 - 757
12345